关键词: 脑梗死; 白蛋白; 治疗结果; 并发症

Abstract: Objective To appraise the effect of Human Albumins in the acute severe cerebral infarction patients.Methods Eighty acute severe cerebral infarction patients were divided into 2 groups. Conventional therapy was applied in the 2 groups, and Human Albumins was used conventionally in treatment group(n=44), whereas it was used in control group(n=36) only when serum albumin was less than 25g/L. Following treatment for 2 weeks, Scandinavian Stroke Scale and Glasgow Coma Scale were evaluated, and the incidence of complications was compared in the 2 groups.Results After treatment, clinical neurologic impairment score of treatment group was significantly lower than that of control group(P<0.05). Coma scale of treatment group was significantly higher than that of control group(P<0.05). The incidence of complications, such as pulmonary infection, renal dysfunction, stress, ulcer and hypoproteinemia, was all higher than that of control group(P<0.05).Conclusion Human Albumins was significant effective for acute severe cerebral infarction patients and could decrease the incidence of complications of severe cerebral infarction patients.

Key words: Brain infarction; Albumins; Treatment outcome; complication